Arcadia Biosciences (RKDA) EBIAT (2016 - 2025)
Historic EBIAT for Arcadia Biosciences (RKDA) over the last 12 years, with Q3 2025 value amounting to $856000.0.
- Arcadia Biosciences' EBIAT rose 15310.17% to $856000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$5.1 million, marking a year-over-year decrease of 29.69%. This contributed to the annual value of -$7.0 million for FY2024, which is 4972.86% up from last year.
- Latest data reveals that Arcadia Biosciences reported EBIAT of $856000.0 as of Q3 2025, which was up 15310.17% from -$4.5 million recorded in Q2 2025.
- Over the past 5 years, Arcadia Biosciences' EBIAT peaked at $3.2 million during Q2 2023, and registered a low of -$9.6 million during Q4 2021.
- For the 5-year period, Arcadia Biosciences' EBIAT averaged around -$2.6 million, with its median value being -$2.9 million (2023).
- The largest annual percentage gain for Arcadia Biosciences' EBIAT in the last 5 years was 20726.37% (2025), contrasted with its biggest fall of 34097.3% (2025).
- Quarter analysis of 5 years shows Arcadia Biosciences' EBIAT stood at -$9.6 million in 2021, then skyrocketed by 54.71% to -$4.3 million in 2022, then surged by 33.76% to -$2.9 million in 2023, then tumbled by 41.75% to -$4.1 million in 2024, then skyrocketed by 121.06% to $856000.0 in 2025.
- Its EBIAT was $856000.0 in Q3 2025, compared to -$4.5 million in Q2 2025 and $2.6 million in Q1 2025.